Abstract
Summary
Erianin, a natural product derived from Dendrobium chrysotoxum, has been used as an analgesic in traditional Chinese medicine and is a potential anti-tumor agent. Erianin can inhibit IDO-induced tumor angiogenesis.
The global market for Erianin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Erianin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Erianin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Erianin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Erianin include Merck, Biosynth Carbosynth, Selleck Chemicals, Clearsynth, LGC, Biorbyt, Taiclone, TargetMol and AK Scientific, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erianin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Erianin by region & country, by Type, and by Application.
The Erianin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erianin.
Market Segmentation
By Company
Merck
Biosynth Carbosynth
Selleck Chemicals
Clearsynth
LGC
Biorbyt
Taiclone
TargetMol
AK Scientific
BioCrick BioTech
Segment by Type:
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Erianin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Erianin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Erianin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Erianin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Erianin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Erianin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Erianin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Erianin include Merck, Biosynth Carbosynth, Selleck Chemicals, Clearsynth, LGC, Biorbyt, Taiclone, TargetMol and AK Scientific, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erianin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Erianin by region & country, by Type, and by Application.
The Erianin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erianin.
Market Segmentation
By Company
Merck
Biosynth Carbosynth
Selleck Chemicals
Clearsynth
LGC
Biorbyt
Taiclone
TargetMol
AK Scientific
BioCrick BioTech
Segment by Type:
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Erianin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Erianin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Erianin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Erianin Product Introduction
1.2 Global Erianin Market Size Forecast
1.2.1 Global Erianin Sales Value (2019-2030)
1.2.2 Global Erianin Sales Volume (2019-2030)
1.2.3 Global Erianin Sales Price (2019-2030)
1.3 Erianin Market Trends & Drivers
1.3.1 Erianin Industry Trends
1.3.2 Erianin Market Drivers & Opportunity
1.3.3 Erianin Market Challenges
1.3.4 Erianin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Erianin Players Revenue Ranking (2023)
2.2 Global Erianin Revenue by Company (2019-2024)
2.3 Global Erianin Players Sales Volume Ranking (2023)
2.4 Global Erianin Sales Volume by Company Players (2019-2024)
2.5 Global Erianin Average Price by Company (2019-2024)
2.6 Key Manufacturers Erianin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Erianin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Erianin
2.9 Erianin Market Competitive Analysis
2.9.1 Erianin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Erianin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erianin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Min Purity Less Than 98%
3.1.2 Min Purity 98%-99%
3.1.3 Min Purity More Than 99%
3.2 Global Erianin Sales Value by Type
3.2.1 Global Erianin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Erianin Sales Value, by Type (2019-2030)
3.2.3 Global Erianin Sales Value, by Type (%) (2019-2030)
3.3 Global Erianin Sales Volume by Type
3.3.1 Global Erianin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Erianin Sales Volume, by Type (2019-2030)
3.3.3 Global Erianin Sales Volume, by Type (%) (2019-2030)
3.4 Global Erianin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research
4.1.2 Medical
4.2 Global Erianin Sales Value by Application
4.2.1 Global Erianin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Erianin Sales Value, by Application (2019-2030)
4.2.3 Global Erianin Sales Value, by Application (%) (2019-2030)
4.3 Global Erianin Sales Volume by Application
4.3.1 Global Erianin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Erianin Sales Volume, by Application (2019-2030)
4.3.3 Global Erianin Sales Volume, by Application (%) (2019-2030)
4.4 Global Erianin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Erianin Sales Value by Region
5.1.1 Global Erianin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Erianin Sales Value by Region (2019-2024)
5.1.3 Global Erianin Sales Value by Region (2025-2030)
5.1.4 Global Erianin Sales Value by Region (%), (2019-2030)
5.2 Global Erianin Sales Volume by Region
5.2.1 Global Erianin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Erianin Sales Volume by Region (2019-2024)
5.2.3 Global Erianin Sales Volume by Region (2025-2030)
5.2.4 Global Erianin Sales Volume by Region (%), (2019-2030)
5.3 Global Erianin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Erianin Sales Value, 2019-2030
5.4.2 North America Erianin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Erianin Sales Value, 2019-2030
5.5.2 Europe Erianin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Erianin Sales Value, 2019-2030
5.6.2 Asia Pacific Erianin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Erianin Sales Value, 2019-2030
5.7.2 South America Erianin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Erianin Sales Value, 2019-2030
5.8.2 Middle East & Africa Erianin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Erianin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Erianin Sales Value
6.2.1 Key Countries/Regions Erianin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Erianin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Erianin Sales Value, 2019-2030
6.3.2 United States Erianin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Erianin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Erianin Sales Value, 2019-2030
6.4.2 Europe Erianin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Erianin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Erianin Sales Value, 2019-2030
6.5.2 China Erianin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Erianin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Erianin Sales Value, 2019-2030
6.6.2 Japan Erianin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Erianin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Erianin Sales Value, 2019-2030
6.7.2 South Korea Erianin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Erianin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Erianin Sales Value, 2019-2030
6.8.2 Southeast Asia Erianin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Erianin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Erianin Sales Value, 2019-2030
6.9.2 India Erianin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Erianin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Erianin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Erianin Product Offerings
7.1.5 Merck Recent Development
7.2 Biosynth Carbosynth
7.2.1 Biosynth Carbosynth Company Information
7.2.2 Biosynth Carbosynth Introduction and Business Overview
7.2.3 Biosynth Carbosynth Erianin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Biosynth Carbosynth Erianin Product Offerings
7.2.5 Biosynth Carbosynth Recent Development
7.3 Selleck Chemicals
7.3.1 Selleck Chemicals Company Information
7.3.2 Selleck Chemicals Introduction and Business Overview
7.3.3 Selleck Chemicals Erianin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Selleck Chemicals Erianin Product Offerings
7.3.5 Selleck Chemicals Recent Development
7.4 Clearsynth
7.4.1 Clearsynth Company Information
7.4.2 Clearsynth Introduction and Business Overview
7.4.3 Clearsynth Erianin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Clearsynth Erianin Product Offerings
7.4.5 Clearsynth Recent Development
7.5 LGC
7.5.1 LGC Company Information
7.5.2 LGC Introduction and Business Overview
7.5.3 LGC Erianin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 LGC Erianin Product Offerings
7.5.5 LGC Recent Development
7.6 Biorbyt
7.6.1 Biorbyt Company Information
7.6.2 Biorbyt Introduction and Business Overview
7.6.3 Biorbyt Erianin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Biorbyt Erianin Product Offerings
7.6.5 Biorbyt Recent Development
7.7 Taiclone
7.7.1 Taiclone Company Information
7.7.2 Taiclone Introduction and Business Overview
7.7.3 Taiclone Erianin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Taiclone Erianin Product Offerings
7.7.5 Taiclone Recent Development
7.8 TargetMol
7.8.1 TargetMol Company Information
7.8.2 TargetMol Introduction and Business Overview
7.8.3 TargetMol Erianin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 TargetMol Erianin Product Offerings
7.8.5 TargetMol Recent Development
7.9 AK Scientific
7.9.1 AK Scientific Company Information
7.9.2 AK Scientific Introduction and Business Overview
7.9.3 AK Scientific Erianin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 AK Scientific Erianin Product Offerings
7.9.5 AK Scientific Recent Development
7.10 BioCrick BioTech
7.10.1 BioCrick BioTech Company Information
7.10.2 BioCrick BioTech Introduction and Business Overview
7.10.3 BioCrick BioTech Erianin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 BioCrick BioTech Erianin Product Offerings
7.10.5 BioCrick BioTech Recent Development
8 Industry Chain Analysis
8.1 Erianin Industrial Chain
8.2 Erianin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Erianin Sales Model
8.5.2 Sales Channel
8.5.3 Erianin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer